US 9925182
Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound
granted A61KA61K31/192A61K31/196
Quick answer
US patent 9925182 (Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound) held by Nektar Therapeutics expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/192, A61K31/196, A61K31/405, A61K31/407